2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34281838 | Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway. | 2021 Aug | 1 |
2 | 32727781 | Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells Via Inactivation of c-Met/PI3K/Akt/mTOR Pathway. | 2020 Aug | 1 |